A building case for Biotech

• Posted by Greg Harmon
• on December 31st, 2015

Biotech has been a crazy hot and volatile sector of the stock market in 2015. It has made millionaires and it has cost people millions. The stories change with each stock and the results of each clinical trial. So without real deep fundamental knowledge the best way to participate in this sector may be through ETF’s. One of the most liquid ETF’s in this space is the iShares Nasdaq Biotechnology ETF ($IBB).

The chart for IBB is below. It had the strong pullback in August and then a second strong leg lower in September on Hillary Clinton’s comments on drug prices. But since that September bottom it has been building a series of higher lows. These have come against resistance at 342, where it sits going into the last day of the year. This creates an ascending triangle. A break above this triangle target a move to 396, awfully close to the July high at 400.

The prospects for this ETF look good into 2016. It has bullish momentum with the RSI rising and in the bullish zone. The MACD is also rising and bullish. And the Bollinger Bands® are opening for a move higher. The lone dark spot is the flat 200 day SMA overhead at 348. A break of the triangle will signal strength in the biotech space and above 348 a confirmed move higher with a solid stop at the 342 triangle level. So much easier than trying to figure which companies will win and which will not.

$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

Still time left. Contact me at greg@dragonflycap.com and use the code SANTA in the message to get either an annual subscription for $556 (10% off) or an annual subscription plus my book signed for $600.

$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

Want to learn more about Dragonfly Capital Views?
Dragonfly Capital Views Performance Through December 2015 and sign up here

If you like what you see above sign up for deeper analysis and trading strategy by using the Get Premium button above. As always you can see details of individual charts and more on my StockTwits page.

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.

blog comments powered by Disqus